About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker CNTX

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Aug 14, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
MPM BioImpact LLC1.30M1.4%SCHEDULE 13G/A ↗
Aug 12, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Blue Owl Capital Holdings LP2.93M3.2%SCHEDULE 13G/A ↗
Jul 31, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Ting Jia3.05M3.3%SCHEDULE 13G/A ↗
Jul 31, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Octagon Investments Master Fund LP3.05M3.3%SCHEDULE 13G/A ↗
Jul 31, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Octagon Capital Advisors LP3.05M3.3%SCHEDULE 13G/A ↗
Jul 27, 2026SCHEDULE 13GCNTX
Context Therapeutics Inc.
BlackRock, Inc.6.17M6.7%SCHEDULE 13G ↗
May 15, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Ms. Lillian Nordahl2.24M2.4%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Dr. Jeffrey R. Jay, M.D.2.24M2.4%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Great Point Partners, LLC2.24M2.4%SCHEDULE 13G/A ↗
May 14, 2026SCHEDULE 13GCNTX
Context Therapeutics Inc.
Ting Jia5.25M5.7%SCHEDULE 13G ↗
May 14, 2026SCHEDULE 13GCNTX
Context Therapeutics Inc.
Octagon Investments Master Fund LP5.25M5.7%SCHEDULE 13G ↗
May 14, 2026SCHEDULE 13GCNTX
Context Therapeutics Inc.
Octagon Capital Advisors LP5.25M5.7%SCHEDULE 13G ↗
May 14, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Blue Owl Capital Holdings LP5.09M5.5%SCHEDULE 13G/A ↗
May 12, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Michael Gregory8.30M8.7%SCHEDULE 13G/A ↗
May 12, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Private Master Fund I LP7.36M7.7%SCHEDULE 13G/A ↗
May 12, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Capital Partners (GP) LLC8.30M8.7%SCHEDULE 13G/A ↗
May 12, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Capital Partners Fund (GP) LP8.30M8.7%SCHEDULE 13G/A ↗
May 12, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Partners Management (GP) LLC8.30M8.7%SCHEDULE 13G/A ↗
May 12, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Partners Management LP8.30M8.7%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Guy Levy6.96M7.6%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Soleus GP, LLC6.96M7.6%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Soleus Capital Management, L.P.6.96M7.6%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Soleus Capital Group, LLC6.96M7.6%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Soleus Capital, LLC6.96M7.6%SCHEDULE 13G/A ↗
May 8, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Soleus Capital Master Fund, L.P.6.96M7.6%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
MPM BioImpact LLC10.68M11.6%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Ms. Lillian Nordahl4.68M5.1%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Dr. Jeffrey R. Jay, M.D.4.68M5.1%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Great Point Partners, LLC4.68M5.1%SCHEDULE 13G/A ↗
Feb 3, 2026SCHEDULE 13GCNTX
Context Therapeutics Inc.
Guy Levy4.78M5.2%SCHEDULE 13G ↗
Feb 3, 2026SCHEDULE 13GCNTX
Context Therapeutics Inc.
Soleus GP, LLC4.78M5.2%SCHEDULE 13G ↗
Feb 3, 2026SCHEDULE 13GCNTX
Context Therapeutics Inc.
Soleus Capital Management, L.P.4.78M5.2%SCHEDULE 13G ↗
Feb 3, 2026SCHEDULE 13GCNTX
Context Therapeutics Inc.
Soleus Capital Group, LLC4.78M5.2%SCHEDULE 13G ↗
Feb 3, 2026SCHEDULE 13GCNTX
Context Therapeutics Inc.
Soleus Capital, LLC4.78M5.2%SCHEDULE 13G ↗
Feb 3, 2026SCHEDULE 13GCNTX
Context Therapeutics Inc.
Soleus Capital Master Fund, L.P.4.78M5.2%SCHEDULE 13G ↗
Nov 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Ms. Lillian Nordahl4.68M5.2%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Dr. Jeffrey R. Jay, M.D.4.68M5.2%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Great Point Partners, LLC4.68M5.2%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Michael Gregory9.20M9.9%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Private Master Fund I LP7.78M8.2%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Private Master Fund I LP7.78M8.2%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Master Fund LP4.51M4.9%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Capital Partners (GP) LLC9.20M9.9%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Capital Partners Fund (GP) LP9.20M9.9%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Partners Management (GP) LLC9.20M9.9%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Avidity Partners Management LP9.20M9.9%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Ms. Lillian Nordahl4.68M5.2%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Dr. Jeffrey R. Jay, M.D.4.68M5.2%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Great Point Partners, LLC4.68M5.2%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)CNTX
Context Therapeutics Inc.
Michael Gregory9.13M9.9%SCHEDULE 13G/A ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 10:10 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances